The molecular changes induced by TRAIL could potentially be utilized to bypass the resistance mechanisms driven by apoptosis, a strategy previously suggested for leukemia but not fully explored in other cancer types (Hu and Xuan, 2008; Hu et al, 2007; Huang et al, 2018). This evidence concerns the gene TNFSF10 and leukemia.